Advertisement
Canada markets open in 6 hours 15 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7329
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    84.10
    +0.53 (+0.63%)
     

  • Bitcoin CAD

    87,739.64
    -21.63 (-0.02%)
     

  • CMC Crypto 200

    1,389.60
    -6.94 (-0.50%)
     

  • GOLD FUTURES

    2,351.70
    +9.20 (+0.39%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,757.50
    +190.00 (+1.08%)
     

  • VOLATILITY

    15.37
    0.00 (0.00%)
     

  • FTSE

    8,121.77
    +42.91 (+0.53%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Accelerate Diagnostics: 4Q Earnings Snapshot

Associated Press
Updated ·1 min read

TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Tuesday reported a loss of $18.9 million in its fourth quarter.

On a per-share basis, the Tucson, Arizona-based company said it had a loss of 33 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.

The maker of systems that diagnose drug-resistant infections posted revenue of $3.1 million in the period.

For the year, the company reported that its loss narrowed to $78.2 million, or $1.40 per share. Revenue was reported as $11.2 million.

ADVERTISEMENT

Accelerate Diagnostics shares have increased 47% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $11.15, a fall of 28% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXDX at https://www.zacks.com/ap/AXDX